HIND
Price
$2.06
Change
-$0.04 (-1.90%)
Updated
Sep 11 closing price
Capitalization
14.46M
73 days until earnings call
Intraday BUY SELL Signals
HURA
Price
$2.05
Change
+$0.02 (+0.99%)
Updated
Sep 11 closing price
Capitalization
130.64M
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HIND vs HURA

HIND vs HURA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HIND vs. HURA commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIND is a Hold and HURA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HURA($131M) has a higher market cap than HIND($14.5M). HURA YTD gains are higher at: 170.913 vs. HIND (-40.116). HIND has higher annual earnings (EBITDA): -11.53M vs. HURA (-29.41M). HIND has more cash in the bank: 7.89M vs. HURA (996K). HIND has less debt than HURA: HIND (17.3K) vs HURA (9.18M). HIND has higher revenues than HURA: HIND (130K) vs HURA (0).
HINDHURAHIND / HURA
Capitalization14.5M131M11%
EBITDA-11.53M-29.41M39%
Gain YTD-40.116170.913-23%
P/E RatioN/AN/A-
Revenue130K0-
Total Cash7.89M996K792%
Total Debt17.3K9.18M0%
FUNDAMENTALS RATINGS
HIND vs HURA: Fundamental Ratings
HIND
HURA
OUTLOOK RATING
1..100
779
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
7662
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HIND's Valuation (38) in the null industry is in the same range as HURA (43). This means that HIND’s stock grew similarly to HURA’s over the last 12 months.

HIND's Profit vs Risk Rating (100) in the null industry is in the same range as HURA (100). This means that HIND’s stock grew similarly to HURA’s over the last 12 months.

HURA's SMR Rating (99) in the null industry is in the same range as HIND (100). This means that HURA’s stock grew similarly to HIND’s over the last 12 months.

HURA's Price Growth Rating (62) in the null industry is in the same range as HIND (76). This means that HURA’s stock grew similarly to HIND’s over the last 12 months.

HURA's P/E Growth Rating (100) in the null industry is in the same range as HIND (100). This means that HURA’s stock grew similarly to HIND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HINDHURA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (HIND: $2.06 vs. HURA: $2.05)
Brand notoriety: HIND and HURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HIND: 245% vs. HURA: 36%
Market capitalization -- HIND: $14.46M vs. HURA: $130.64M
HIND [@Biotechnology] is valued at $14.46M. HURA’s [@Biotechnology] market capitalization is $130.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIND’s FA Score shows that 0 FA rating(s) are green while HURA’s FA Score has 0 green FA rating(s).

  • HIND’s FA Score: 0 green, 5 red.
  • HURA’s FA Score: 0 green, 5 red.
According to our system of comparison, HURA is a better buy in the long-term than HIND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIND’s TA Score shows that 3 TA indicator(s) are bullish while HURA’s TA Score has 2 bullish TA indicator(s).

  • HIND’s TA Score: 3 bullish, 6 bearish.
  • HURA’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, both HIND and HURA are a bad buy in the short-term.

Price Growth

HIND (@Biotechnology) experienced а -7.21% price change this week, while HURA (@Biotechnology) price change was -4.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

HIND is expected to report earnings on Nov 24, 2026.

HURA is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
HIND
Daily Signal:
Gain/Loss:
HURA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFESX22.800.18
+0.80%
DFA Emerging Markets Social Core Port
NRILX16.100.08
+0.50%
Neuberger International Sel R6
FEAAX83.68N/A
N/A
Fidelity Advisor Emerging Asia A
TGRYX12.86N/A
N/A
TCW Global Real Estate N
PJFOX72.27N/A
N/A
PGIM Jennison Growth R2

HIND and

Correlation & Price change

A.I.dvisor indicates that over the last year, HIND has been loosely correlated with IMMP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HIND jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIND
1D Price
Change %
HIND100%
-1.90%
IMMP - HIND
36%
Loosely correlated
+14.83%
MTNB - HIND
35%
Loosely correlated
-9.76%
CLDX - HIND
32%
Poorly correlated
-3.15%
PHAT - HIND
30%
Poorly correlated
-0.12%
HURA - HIND
30%
Poorly correlated
+0.99%
More

HURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HURA has been loosely correlated with CMND. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HURA jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HURA
1D Price
Change %
HURA100%
+0.99%
CMND - HURA
37%
Loosely correlated
-1.52%
SNTI - HURA
36%
Loosely correlated
+1.93%
CLDX - HURA
31%
Poorly correlated
-3.15%
HIND - HURA
30%
Poorly correlated
-1.90%
NKTR - HURA
27%
Poorly correlated
-1.26%
More